´Ù¹ß°ñ¼öÁ¾¿¬±¸È¸ 2021 ÇϹݱâ KMMWP(Korean Multiple Myleloma Working Party) workshop & Àӻ󿬱¸¸ðÀÓ : 2021-11-20±³À°ÀÏÀÚ : 2021-11-20
±³À°Àå¼Ò : ¼¼Á¾´ëÇб³ ±¤°³Åä°ü B2, B-C hall
±³À°ÁÖÁ¦ :
2021 ÇϹݱâ KMMWP(Korean Multiple Myleloma Working Party) workshop & Àӻ󿬱¸¸ðÀÓÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´Ù¹ß°ñ¼öÁ¾¿¬±¸È¸
´ã´çÀÚ : ¼È¿Áø
¿¬¶ôó : 02-516-6581
À̸ÞÀÏ :
kmmwp_office@naver.com ±³À°Á¾·ù : ³»°ú, Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 50¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í COVID-19·Î ÀÎÇÏ¿© »çÀüµî·ÏÀÌ Á¶±â ¸¶°¨ µÉ ¼ö ÀÖ½À´Ï´Ù.
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-20 ¼¼Á¾´ëÇб³ ±¤°³Åä°ü B-C hall 09:40~10:10 Clinical perspective on MRD assessment in MM Á¶Çö¼ö(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-20 ¼¼Á¾´ëÇб³ ±¤°³Åä°ü B-C hall 10:10~10:40 Updates of MRD testing in MM ÀÓÁöÇâ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-20 ¼¼Á¾´ëÇб³ ±¤°³Åä°ü B-C hall 10:40~11:10 How to up NGF MM MRD? Ȳ»ó¹Ì(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-20 ¼¼Á¾´ëÇб³ ±¤°³Åä°ü B-C hall 11:20~11:50 Insurance issues of NGF ÃÖÁ¤À±(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-20 ¼¼Á¾´ëÇб³ ±¤°³Åä°ü B-C hall 11:50~12:20 Education center or Regional hub center for NGF Á¶´ö(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-20 ¼¼Á¾´ëÇб³ ±¤°³Åä°ü B-C hall 13:20~13:50 Diagnosis and management of paraprotein-related peripheral neuropathies ¹Ú¿µÈÆ(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 11-20 ¼¼Á¾´ëÇб³ ±¤°³Åä°ü B-C hall 13:50~14:20 Recent issues of COVID-19: management, vaccination, and near future À̵¿°Ç(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-20 ¼¼Á¾´ëÇб³ ±¤°³Åä°ü B-C hall 14:30~15:50 Àӻ󿬱¸ I (currently active protocol) ¾öÇö¼®(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 11-20 ¼¼Á¾´ëÇб³ ±¤°³Åä°ü B-C hall 15:50~17:00 Àӻ󿬱¸ II (new protocol proposal) µµ¿µ·Ï(°è¸íÀÇ´ë)